广发纳斯达克生物科技美元(001093)
动态评分： 5.90分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | TRML | Tourmaline Bio Inc | 7.84 | 0.05% |
| 2024-12-31 | SVRA | Savara Inc | 7.95 | 0.05% |
| 2024-12-31 | PAHC | 美国辉宝 | 6.45 | 0.04% |
| 2024-12-31 | ARCT | Arcturus Therapeutics Holdings Inc | 6.94 | 0.04% |
| 2024-12-31 | XERS | Xeris制药 | 7.63 | 0.04% |
| 2024-12-31 | ANAB | AnaptysBio Inc | 6.08 | 0.04% |
| 2024-12-31 | KALV | KalVista Pharmaceuticals Inc | 6.23 | 0.04% |
| 2024-12-31 | MGTX | MeiraGTx Holdings plc | 7.18 | 0.04% |
| 2024-12-31 | THRD | Third Harmonic Bio Inc | 7 | 0.04% |
| 2024-12-31 | ATXS | Astria Therapeutics Inc | 7.62 | 0.04% |
| 2024-12-31 | OABI | OmniAb Inc | 6.47 | 0.04% |
| 2024-12-31 | TKNO | Alpha Teknova Inc | 6.72 | 0.04% |
| 2024-12-31 | ALT | Altimmune Inc | 7.74 | 0.04% |
| 2024-12-31 | ESPR | Esperion Therapeutics Inc | 6.54 | 0.04% |
| 2024-12-31 | SIGA | 西佳科技 | 6.48 | 0.04% |
| 2024-12-31 | EYPT | EyePoint Pharmaceuticals Inc | 7.67 | 0.04% |
| 2024-12-31 | PACB | Pacific Biosciences of California Inc | 7.56 | 0.04% |
| 2024-12-31 | VERV | Verve Therapeutics Inc | 7.21 | 0.04% |
| 2024-12-31 | HCM | 和黄医药(US ADR) | 6.74 | 0.04% |
| 2024-12-31 | RNAC | Cartesian Therapeutics Inc | 6.87 | 0.04% |
公告&资料
